[VIVO] YoY Quarter Result on 31-Mar-2016 [#Q2]

Stock
[VIVO] Meridian Bioscience, Inc.
Announcement Date
06-May-2016
Financial Year
2016
Quarter
31-Mar-2016 [#Q2]
Profit Trend
QoQ- 2.23%
YoY- -9.72%
Quarter Report
VIVO's Result
VIVO's Financial Summary
View:
Show?
Quarter Result
31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 CAGR
Revenue 50,248 56,451 54,125 51,259 51,545 50,134 47,265 1.02%
PBT 9,247 7,224 14,190 14,792 15,527 15,644 15,529 -8.27%
Tax 2,153 1,936 4,878 5,701 5,457 5,344 5,280 -13.88%
NP 7,094 5,288 9,312 9,091 10,070 10,300 10,249 -5.94%
Tax Rate -23.28% -26.80% -34.38% -38.54% -35.15% -34.16% -34.00% -
Total Cost 43,154 51,163 44,813 42,168 41,475 39,834 37,016 2.58%
Ratio Analysis
31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 CAGR
NP Margin 14.12 9.37 17.20 17.74 19.54 20.54 21.68 -6.89%
Per Share
31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 CAGR
EPS 0.17 0.12 0.22 0.22 0.24 0.25 0.25 -6.22%
EPS Diluted 0.17 0.12 0.22 0.21 0.24 0.24 0.24 -5.58%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.